Stephens & Co. Reiterates Equal-Weight on Insight Molecular, Maintains $4 Price Target

Benzinga · 1d ago
Stephens & Co. analyst Mason Carrico reiterates Insight Molecular (NASDAQ:IMDX) with a Equal-Weight and maintains $4 price target.